Nuo Therapeutics, Inc. - 8-K Filing
Nuo Therapeutics reports Q3 2026 total revenue of $1.9 million, an 80% increase year-over-year. (Items: 2.02 Results of Operations and Financial Condition On November 16, 2026, Nuo Therapeutics, Inc, 9.01 Financial Statements and Exhibits (d) Exhibits Exhibit No)
Tickers: $AURX